Conditions: Epilepsy
Keywords: Epilepsy ESL Eslicarbazepine Acetate BIAL BIA Partial-onset Seizures
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 72
Healthy volunteers: no

Brief summary:
This is an open Label study to investigate the safety and efficacy of eslicarbazepine acetate as adjunctive therapy for partial seizures in elderly patients.

Detailed description:
Multicenter study in approximately 100 elderly patients. The study will follow an open-label design and will consist of 8-week baseline period, followed by a 26-week treatment period and a 4-week follow-up period.

Arms:
arm 1: None

Interventions: intervention 1: Eslicarbazepine Acetate
Intervention descriptions: intervention 1: ESL tablets (800 mg) QD

Protocol document: